GLP1 receptor agonists attenuate systemic inflammation through microbiota mediated enrichment of Faecalibacterium prausnitzii and Roseburia spp
Hiroshi Tanaka, Yuki Nakamura, Ayaka Fujimoto, Kenji Sato, Mika Suzuki
This study shows GLP-1 receptor agonists reduce systemic inflammation by increasing Faecalibacterium prausnitzii and Roseburia spp. in the gut microbiota, unlike NSAIDs.
bioRxiv · Sep 7, 2025 · PreprintImmunology